Catalog Pro5® MHC Class I Pentamers

Pentamer Research Areas:

AAVAdenovirusAutoimmunityBK Virus
CancerChlamydiaCMVCOVID-19 / SARS-CoV-2
DengueEBVHAVHBV
HCVHIV/SIVHPVHSV
HTLVInfluenzaJC VirusLCMV
ListeriaMalariaMiHAgModel Antigens
MuLVNegativeNorovirusOther
RSVSendai VirusSV40 VirusToxoplasma gondii
TrypanosomaTuberculosisVacciniaVaricella Zoster Virus
VSVWest Nile VirusYellow Fever Virus

Search the table below by disease, allele, specificity or sequence, or any combination, e.g. “CMV A*02:01 pp65”. If your specificity is not listed, we can synthesize Custom MHC Class I Pentamers at no additional cost.

DISEASEALLELEPEPTIDE CODEPEPTIDE SEQUENCEEPITOPE ORIGIN
AAVA*01:01886SADNNNSEYAAV VP1 492-500
AAVB*07:02651VPQYGYLTLAAV2 372-380
AdenovirusA*01:01686TDLGQNLLYAdenovirus 5 Hexon 886-894
AdenovirusA*24:02684TYFSLNNKFAdenovirus 5 Hexon 37-45
AdenovirusB*07:02685KPYSGTAYNSLAdV Hexon
AdenovirusB*07:02989KPYSGTAYNALAdenovirus Hexon 114-124
AdenovirusB*35:011346IPYLDGTFYAdV Hexon
AdenovirusH-2Db2206SGPSNTPPEIAd5 E1A 234-243
AutoImmunityA*02:01151KLQVFLIVLT1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13
AutoImmunityA*02:01393VMNILLQYVGAD65 114-123
AutoImmunityA*02:01470SLSRFSWGAMyelin basic protein 110-118
AutoImmunityA*02:01851HLVEALYLVInsulin B chain 10-18
AutoImmunityA*02:01954LNIDLLWSVT1D Diabetes IGRP 228-236
AutoimmunityA*02:011904VLFGLGFAIT1D Diabetes IGRP 265-273
AutoimmunityA*02:012259ALWGPDPAAAProinsulin precursor 15-24
AutoimmunityA*02:012382MVWESGCTVIA-2 797-805
AutoimmunityA*02:013342YTCPLCRAPVSSA SS-56 55-64
AutoimmunityA*02:013394VIVMLTPLVIA-2 805-813
AutoimmunityA*02:01969RLLPLLALLInsulin Precursor 76-90
AutoimmunityH-2Db1107RSPFSRVVHLMOG Precursor 69-78
AutoimmunityH-2Kd
580VYLKTNVFLIGRP (206-214)
BK virusA*02:011516AITEVECFLVP1 44-52
BK virusA*02:011783FLHCIVFNVlarge T antigen 410-418
BK virusA*02:013781LLMWEAVTVVP1 108-116
BK virusA*02:013903CLLPKMDSVlarge T antigen 398-406
BK virusB*07:022070LPLMRKAYLLT antigen 27-35
CancerA*01:0129EADPTGHSYMAGE-A1 161-169
CancerA*01:0130EVDPIGHLYMAGE-A3 168-176
CancerA*01:01307KSDICTDEYTyrosinase 243-251 (244S)
CancerA*01:01467KCDICTDEYTyrosinase 243-251
CancerA*01:011542QSLEIISRYMcl-1 177-185
CancerA*01:012102YVDFREYEYYFLT3 ITD
CancerA*01:013383TLDTLTAFYMesothelin 429-437
CancerA*01:013622LTDDRLFTCYPLEKHM2
CancerA*01:013623DSDPDSFQDYTyr A1a 454-463
CancerA*01:013624EADPIGHLYMAGEA3
CancerA*01:013626EVDPASNTYMAGE-A4 169-177
CancerA*01:013627HSTNGVTRIYPSMA
CancerA*01:013628ILDTAGREEYN-ras 55-64
CancerA*01:013630LVDVMPWLQYCytochrome P450 240-249
CancerA*01:013632RSDSGQQARYAIM-2
CancerA*01:013633VTEPGTAQYMinor antigen HA-3T (Lbc oncogene 451-459)
CancerA*01:013634VYDFFVWLHYTRP-2 181-190
CancerA*02:0134FLWGPRALVMAGEA3 271-279
CancerA*02:0146IMDQVPFSVgp100 (pmel17) 209-217
CancerA*02:0147YLEPGPVTVgp100 (pmel) 280-288 (288V)
CancerA*02:0148YLSGADLNLCarcinoembryonic antigen (CEA)-derived peptide CAP1-6D
CancerA*02:0149SLLMWITQCNY-ESO-1 157-165 (9C)
CancerA*02:0157KTWGQYWQVgp100 (pmel17) 154-162
CancerA*02:0158YLEPGPVTAgp100
CancerA*02:0161YMDGTMSQVTyrosinase 369-377 (371D)
CancerA*02:0175YLSGANLNLCarcinogenic Embryonic Antigen (CEA) 571-579
CancerA*02:0182ELAGIGILTVMelanA / MART 26-35
CancerA*02:0185ILAKFLHWLTelomerase 540-548
CancerA*02:0186ALQPGTALLProstate Stem Cell Antigen (PSCA) 14-22
CancerA*02:0197VISNDVCAQVProstate Specific Antigen-1 (PSA-1) 154-163
CancerA*02:01117RLVDDFLLVTelomerase Reverse Transcriptase 865-873
CancerA*02:01125GVLVGVALICarcinogenic Embryonic Antigen (CEA) 694-702
CancerA*02:01157VLYRYGSFSVgp100 (pmel17) 476-485
CancerA*02:01162PLFQVPEPVAlpha-fetoprotein isoform 1 137-145
CancerA*02:01163FMNKFIYEIHuman alfa fetoprotein 158-166
CancerA*02:01164GLSPNLNRFLAlpha-fetoprotein isoform 2 167-176
CancerA*02:01171KVLEYVIKVMAGEA1 278-286
CancerA*02:01205LLGRNSFEVp53 264-272
CancerA*02:01208LLLLTVLTVMUC-1 12-20
CancerA*02:01210ILHNGAYSLHER-2/neu 435-443
CancerA*02:01212RLLQETELVHER-2/neu 689-697
CancerA*02:01214KIFGSLAFLHER-2/neu 369-377
CancerA*02:01220LLLLDVAPLHSP1A 459-467
CancerA*02:01221LLDVAPLSLHSP1A 461-469
CancerA*02:01226HLYQGCQVVReceptor tyrosine-protein kinase erbB-2 48-56
CancerA*02:01249HLSTAFARVG250 (renal cell carcinoma) 217-225
CancerA*02:01250VLQELNVTVLeukocyte Proteinase-3 (Wegener's autoantigen) 169-177
CancerA*02:01302KVAELVHFLMAGEA3 112-120
CancerA*02:01304VLAGVGFFIEPHA2 550-558
CancerA*02:01306FLYTLLREVSTEAP 86-94
CancerA*02:01329ILLWQPIPVProstatic Acid Phosphatase-3 (PAP-3) 135-143
CancerA*02:01337RLQEERTCKVBIR
CancerA*02:01338QLCPICRAPVLivin/ML-IAP280 175-184
CancerA*02:01345VLGEAWRDQVTRAP 45-54
CancerA*02:01381LLLTVLTVVTumor Mucin Antigen 13-21
CancerA*02:01389GLYDGMEHLMAGEA-10 254-262
CancerA*02:01390SLLMWITQVNY-ESO-1 157-165
CancerA*02:01391LMLGEFLKLSurvivin 96-104
CancerA*02:01394YLFFYRKSVmTERT 572-580
CancerA*02:01404FLTPKKLQCVProstate Specific Antigen-1 (PSA-1) 141-150
CancerA*02:01405KLQCVDLHVProstate Specific Antigen 146-154
CancerA*02:01408TLAPATEPAMucin 79-87
CancerA*02:01447YLQVNSLQTVTelomerase Reverse Transcriptase (hTRT) 988-997
CancerA*02:01452SLGEQQYSVWT1 187-195
CancerA*02:01457SLEENIVILRHAMM 275-283
CancerA*02:01464YMNGTMSQVTyrosinase 368-376
CancerA*02:01468ILSLELMKLReceptor for hyaluronic acid-mediated
motility (RHAMM) 165-173
CancerA*02:01480PLFDFSWLSLBcl-2 208-217
CancerA*02:01516LLGATCMFVCyclinD 101-109
CancerA*02:01527ALYVDSLFFLPRAME PRA 300-309
CancerA*02:01560GLMEEMSALHuman Mena protein (overexpressed in breast cancer)
CancerA*02:01561TMNGSKSPVhMena 502-510
CancerA*02:01575GVYDGREHTVMAGE-A4 230-239
CancerA*02:01594YLNDHLEPWIBcl-X 173-182
CancerA*02:01599ALDVYNGLLProstatic acid phosphatase precursor (PAP) 299-307
CancerA*02:01600ALFDIESKVPSM P2 (prostate)
CancerA*02:01637SLAMLDLLHVMutant anaplastic lymphoma kinase 1220-1229
CancerA*02:01645YLNTVQPTCVEGF-R 1138-1147
CancerA*02:01646KLFGTSGQKTEGF-R-479 350-359
CancerA*02:01654RMPEAAPPVp53 65-73
CancerA*02:01655KLVVVGADGVKRAS G12D (5-14)
CancerA*02:01752KLVVVGAVGVKRAS G12V (5-14)
CancerA*02:01662PLTSIISAVReceptor tyrosine-protein kinase erbB-2 728-736
CancerA*02:01689VLAGGFFLLPSMA 27-38
CancerA*02:01690LLHETDSAVPSMA/PSM-P1 4-12
CancerA*02:01693VMAGVGSPYVReceptor tyrosine-protein kinase erbB-2 819-828
CancerA*02:01773VLPLTVAEVMesothelin 530-538
CancerA*02:01774SLLFLLFSLMesothelin 20-28
CancerA*02:01780QLFEELQELHeme oxygenase-1 212-220
CancerA*02:01781VLDGLDVLLPRAME 100-108
CancerA*02:01787RLASFYDWPLBIR7 90-99
CancerA*02:01810LIAHNQVRQVHER-2/neu (85-94)
CancerA*02:01811ILHDGAYSLHER-2 434-443
CancerA*02:01813FVGEFFTDVGPC3 144-152 (overexpressed in hepatocellular carcinoma)
CancerA*02:01841LLLIWFRPVBKV Ltag 579-587
CancerA*02:01859KLQDASAEVHM1.24-aa 126-134
CancerA*02:01861SLLQHLIGLPRAME 425-433
CancerA*02:01862VIFDFLHCIBKV Ltag 406-414
CancerA*02:01893VLDFAPPGAWT1
CancerA*02:01915TLPGYPPHVPAX-5 311-319
CancerA*02:01921YMEHNNVYTVFibromodulin 250-259
CancerA*02:01922YLQHNEIQEVFibromodulin 206-215
CancerA*02:01958SLVDVMPWLCytochrome p450 1B1 239-248
CancerA*02:01960RLMNDMTAVHSP105 128-136
CancerA*02:01997RLARLALVLTrophoblast glycoprotein 17-25
CancerA*02:01998FLTGNQLAV5T4 97-105
CancerA*02:011007LLLAGLFSLFibromodulin 7-15
CancerA*02:011013FLGYLILGVProstatic Acid Phosphatase-3 (PAP-3)
CancerA*02:011056SLFLGILSVCD20 188-196 (B cell malignancies)
CancerA*02:011130AVLPLLELVMCL-1 139-147
CancerA*02:011181SLSEKTVLLCD59 glycoprotein precursor 106-114
CancerA*02:011201YMCSFLFNLEwing Tumor EZH2 666-674
CancerA*02:011239YLISGDSPVCD33 65-73 (1Y2L)
CancerA*02:011246KASEKIFYVSSX2 41-49
CancerA*02:011302FLAKLNNTVHCA587 317-325
CancerA*02:011386GLAPPQHLIRVp53 187-197
CancerA*02:011403VIMPCSWWVChondromodulin-I 319-327
CancerA*02:011421KVVEFLAMLMAGE-C1 1083-1091
CancerA*02:011464LTLGEFLKLSurvivin-3A 96-104
CancerA*02:011508ALPFGFILVIL13R 345-353
CancerA*02:011509TLADFDPRVEphA2
CancerA*02:011778ALMEQQHYVITGB8 662-670
CancerA*02:011779CLTSTVQLVHER-2/neu 789-797
CancerA*02:011786GLLGASVLGLTelomerase Reverse Transcriptase (hTRT) 674-683
CancerA*02:011908QLLDGFMITLPASD1 39-48
CancerA*02:011910YLVGNVCILPASD1 168-176
CancerA*02:011920ALLTSRLRFITelomerase Reverse Transcriptase (hTRT) 615-624
CancerA*02:011937RLSSCVPVA131-139
CancerA*02:012079FLYDDNQRVTopoisomerase II-alpha-b 828-836
CancerA*02:012081YLIELIDRVTACE 250-258
CancerA*02:012083FLAEDALNTVEpithelial Discoidin Domain Receptor 1 (EDDR1) 867-876
CancerA*02:012236GLMKYIGEVTRPM8 187-195
CancerA*02:012291AILALLPALProstate Stem Cell Antigen (PSCA) 105-133
CancerA*02:012293GLQHWVPELBA46 (Lactadherin) 97-106
CancerA*02:012294GVRGRVEEIBCR-ABL
CancerA*02:012296ITDQVPFSVgp100 (pmel) 209-217
CancerA*02:012297KLCPVQLWVp53 139-147
CancerA*02:012298KVAEELVHFLMAGEA3 112-120 (alternative version)
CancerA*02:012299SLPPPGTRVp53 149-157
CancerA*02:012300YLGSYGFRLp53 103-111
CancerA*02:012301YLQLVFGIEVMAGEA2 157-166
CancerA*02:012371TLQDIVYKLBMI1 74-82
CancerA*02:012457YAIDLPVSVL-dopachrome tautomerase 488-496
CancerA*02:012569AMVGAVLTATyrosinase 482-190
CancerA*02:012582ATVGIMIGVCEACAM5 687-695
CancerA*02:012649YVDPVITSIHepatocyte growth factor receptor 673-681
CancerA*02:012669GVLLWEIFSLVEGFR1 28-37
CancerA*02:012778GLSNLTHVLPRAME (432-440)
CancerA*02:012793LMAQEALAFLCAMEL 2-11
CancerA*02:012860ALLPAVPSLWilms Tumor Protein 83-91
CancerA*02:012988RVA(PHOSPHO-S)PTSGVInsulin receptor substrate-2 1097-1105
CancerA*02:012990RVASPTSGVIRS-2 1097-1105
CancerA*02:013006KVDELAHFLMelanoma-associated antigen 4 (MAGE4) 113-121
CancerA*02:013080KVLEHVVRVMelanoma-associated antigen 4 (MAGE4) 286-294
CancerA*02:013343ALNVYNGLLACPP 299-307
CancerA*02:013344ALSPVPPVVBcl-2 85-93
CancerA*02:013345ALVCYGPGIFAP alpha 463-471
CancerA*02:013346ALWPWLLMATRNF43 11-20
CancerA*02:013347ALYLMELTMCB9L2
CancerA*02:013350CLPSPSTPVBMI1 271-279
CancerA*02:013352ELSDSLGPVPASD1 695-703
CancerA*02:013355FLFLRNFSLTARP(V28L)27-35
CancerA*02:013356FLPSPLFFFLTARP(P5L) 5-13
CancerA*02:013357GLFKCGIAVFAP 639-647
CancerA*02:013358GLIQLVEGVTRAG-3 4-12
CancerA*02:013361ILGVLTSLVDLK1 309-317
CancerA*02:013363LLVPTCVFLV691-700
CancerA*02:013365MLAVFLPIVSTEAP 292-300 (293L)
CancerA*02:013366NLFETPVEA194-202
CancerA*02:013368QLGEQCWTVPSCA 44-51 (51A)
CancerA*02:013371RLAEYQAYISART3 309-317
CancerA*02:013374SIDWFMVTVp31-39
CancerA*02:013375SILLRDAGLVTRAG-3 57-66
CancerA*02:013377SLFEPPPPGPSMA 85-93
CancerA*02:013379SQADALKYVEZH2 729-737
CancerA*02:013386WLSLKTLLSLBcl-2 214-223
CancerA*02:013387YLNRHLHTWIBCL-2 180-189
CancerA*02:013388YLQWIEFSIProminin1 744-752
CancerA*02:013389YLYQWLGAPVOsteocalcin 51-60
CancerA*02:013416KLMSSNSTDLHSP105 234-243
CancerA*02:013417SLYSYFQKVMembrane-associated transporter protein
CancerA*02:013436RLQGISPKISSX2 103-111
CancerA*02:013636AILALLPALLPSCA
CancerA*02:013638ALIHHNTHLHER2 466-474
CancerA*02:013641CMHLLLEAVMG50 624-632
CancerA*02:013643FLIIWQNTMFSP26
CancerA*02:013644FLPWHRLFLLTyrosinase 207-216
CancerA*02:013647FVWLHYYSVTRP2 185-193(L)
CancerA*02:013648GLFGDIYLACSNK1A1 26-34
CancerA*02:013649GLFGDIYLAICSNK1A1 26-35
CancerA*02:013654ILLRDAGLVTRAG-3L 58-66
CancerA*02:013655ILLVVVLGVReceptor tyrosine-protein kinase erbB-2 707-715
CancerA*02:013656ILNAMIAKIHAUS3 154-162
CancerA*02:013658KASEYLQLVMAGEA2 153-161
CancerA*02:013659KIWEELSVLMAGEA3 220-228
CancerA*02:013660KLIDRTE(S)LLSP1 325-333
CancerA*02:013661KLTGDENFTITyrosinase precursor 224-233
CancerA*02:013662LLCYSCKAQVPSCA 17-26
CancerA*02:013666LLLEAVPAVMG50 69-77
CancerA*02:013668LLNQLQVNLMucin2 467-475
CancerA*02:013669LLRDAGLVKMTRAP 59-68
CancerA*02:013670LLRRYNVAKVSOX11 266-275
CancerA*02:013671LLSHGAVIEVAnkyrin NYBR1 158-167
CancerA*02:013673LVFGIELMEVMAGEA3 160-169
CancerA*02:013674LVFGIEVVEVMAGEA12 160-169
CancerA*02:013675MLWGWREHVMucin2 645-653
CancerA*02:013678PLQPEQLQVReceptor tyrosine-protein kinase erbB-2 437-445
CancerA*02:013680QLMAFNHLIPAX3/FKHR 135-143
CancerA*02:013681QLMPYGCLLReceptor tyrosine-protein kinase erbB-2 845-853
CancerA*02:013684RLGPTLMCLMG50 1244-1252
CancerA*02:013687RLTRFLSRVCyclinD 228-236
CancerA*02:013688RTF(S)PTYGLDesmuslin 426-434
CancerA*02:013689SILLRDAGLTRAP 57-65
CancerA*02:013691SLADEAEVYLGAS7 Neoepitope
CancerA*02:013693SLDDYNHLVL-dopachrome tautomerase 288-296
CancerA*02:013695SLYKFSPFPLO-linked N-acetylglucosamine transferase FSP06
CancerA*02:013696SMTR(S)PPRVSFRS2B 241-249
CancerA*02:013698TLEEITGYLReceptor tyrosine-protein kinase erbB-2 448-456
CancerA*02:013699TLHCDCEILMG50 210-218
CancerA*02:013702VLEPPGARDVBIR 7 230-239
CancerA*02:013704VLLALLMAGLProstate stem cell antigen 4-13
CancerA*02:013705VLSVNVPDVMG50 625-633
CancerA*02:013706VLVKSPNHVReceptor tyrosine-protein kinase erbB-4 890-898
CancerA*02:013708VMIG(S)PKKVTensin3 1558-1566
CancerA*02:013709VVLGVVFGIReceptor tyrosine-protein kinase erbB-2 743-751
CancerA*02:013710WLPKILGEVMG50 1051-1059
CancerA*02:013711WLQYFPNPVCytochrome P450 246-254
CancerA*02:013713YLLDLSTNHLFibromodulin 7-15
CancerA*02:013715YLWWVNNQSLCEA 176-185
CancerA*02:013718ALGGHPLLGVDickkopf-related protein 1 20-29
CancerA*02:013719ALLAGLVSLFGFR4 676-684
CancerA*02:013720ALLTYMIAHIThymidylate synthase 231-240
CancerA*02:013721ALMDKSLHVMART-1 56-64
CancerA*02:013722ALPPPLMLLHeparanase 8-16
CancerA*02:013723ALSVMGVYVMAGEA9 223-231
CancerA*02:013724ALVEFEDVLhnRNP L 140-148
CancerA*02:013725ALWPWLLMARNF43 11-19
CancerA*02:013726AMLGTHTMEVMelanocyte-specific secreted glycoprotein 184-193
CancerA*02:013728AVIGALLAVMelanocyte-specific secreted glycoprotein 20-28
CancerA*02:013730CLYGNVEKVhnRNP L 404-412
CancerA*02:013731DLIFGLNALHeparanase 185-193
CancerA*02:013732ELFQDLSQLETV5 54-53
CancerA*02:013733FAWERVRGLCyclin-dependent kinase inhibitor 1 97-105
CancerA*02:013734FIASNGVKLVACTN4 118-127 (K5N)
CancerA*02:013735FLALIICNATubulin beta 4 283-291
CancerA*02:013736FLDEFMEGVMalic enzyme 224-232
CancerA*02:01202ARMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerA*02:01543ALCNTDSPLiLR1
CancerA*02:01550ALKDVEERVMAGE-C2 336-344
CancerA*02:01628LLAARAIVAIiLR1 59-68
CancerA*02:01884RLWQELSDIcircadian clock protein PASD1 691-700
CancerA*02:011303LLFGLALIEVMAGE-C2 191-200
CancerA*02:012194YLNPSVDSVEWS-FLI-1 oncogene
CancerA*02:012282FLDPRPLTVCYP190
CancerA*02:013418STLCQVEPVMPP11
CancerA*02:013419VLQMKEEDViLR1
CancerA*02:013420AIQDLCLAVNPM1
CancerA*02:013421QLLIKAVNLMPP11
CancerA*02:013422AIQDLCVAVNPM1
CancerA*02:013423ALTPVVVTLcyclin-dependent kinase 4 170-178
CancerA*03:0187KQSSKALQRbcr-abl 210 kD fusion protein 21-29
CancerA*03:01118ALLAVGATKgp100 (pmel17) 17-25
CancerA*03:01264ATGFKQSSKbcr-abl 210 kD fusion protein 259-269
CancerA*03:01541RISTFKNWPKSurvivin-3A 18-27 (27K)
CancerA*03:01552RLGLQVRKNKRhoC 176-185 (177L)
CancerA*03:01615RLLFFAPTRMcl-1 95-103
CancerA*03:013369QVLKKIAQKHMOX1 145-153
CancerA*03:013370RIAAWMATY165-173
CancerA*11:01785VVGAVGVGKKRAS G12V (8-16)
CancerA*11:013070VVVGADGVGKKRAS G12D (7-16)
CancerA*11:013072VVVGAVGVGKKRAS G12V (7-16)
CancerA*24:02209TYACFVSNLCarcinogenic Embryonic Antigen (CEA) 652-660
CancerA*24:02230AFLPWHRLFTyrosinase 188-196
CancerA*24:02237IMPKAGLLIMAGE-A3
CancerA*24:02238VYFFLPDHLgp100-intron 4 (170-178)
CancerA*24:02416EYLQLVFGIMAGEA2 156-164
CancerA*24:02417TYLPTNASLHER-2/neu 63-71
CancerA*24:02418VYGFVRACLTelomerase reverse transcriptase (hTRT) 461-469
CancerA*24:02421TFPDLESEFMAGEA3 97-105
CancerA*24:021064DYLQYVLQIMiHA ACC1 15-23
CancerA*24:021806RYCNLEGPPILymphocyte antigen 6 complex locus K (LY6K) 177-186
CancerA*24:022302AYACNTSTLSurvivin 80-88
CancerA*24:022303CYASGWGSIProstate Specific Antigen-1 153-161
CancerA*24:023351DYLNEWGSRFCDH3 807-816
CancerA*24:023353EYCPGGNLFMELK 87-95 (93N)
CancerA*24:023354EYYELFVNIDEP DC1 294-302
CancerA*24:023360GYCTQIGIFHENMT1 221-229
CancerA*24:023362IYTWIEDHFFOXM1 262-270
CancerA*24:023367NYQPVWLCLRNF43 721-729 (722Y)
CancerA*24:023372RYNAQCQETIMidkine 110-119
CancerA*24:023380EYRALQLHLCA9 219-227
CancerA*24:023382SYRNEIAYLTTK protein kinase 551-559
CancerA*24:023384VYLRVRPLLKIF20A 67-75
CancerA*24:023385VYYNWQYLLIL13r 146-154
CancerA*29:023397KEKYIDQEELHSP90 alpha 280-288 (Pathologic Conditions)
CancerA*68:013398TVSGNILTIRNY-ESO-1 127-136
CancerB*07:022304LPWHRLFLLTyrosinase 208-216
CancerB*07:022369EPR(PHOSPHO-S)PSHSMInsulin receptor substrate 2
CancerB*07:023239TPNQRQNVCP2X5
CancerB*07:023348APRGVRMAVLAGE-1 46-54
CancerB*07:023364LPVSPRLQLCEACAM 185-193
CancerB*07:023378SPFFLLLLLTumor Mucin antigen 7-15
CancerB*08:0194GFKQSSKALbcr-abl 210 kD fusion protein 19-27
CancerB*27:05424GRFGLATEKBRAF 594-601 (600E)
CancerB*27:053359GRFGLATVKBRAF 594-601 (600V)
CancerB*27:05202BRMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerB*35:012307MPFATPMEANY-ESO-1 94-102
CancerH-2Db1731ATFKNWPFLMurine Survivin 20-28
CancerH-2Db2415YSSDNLYQMWilms Tumor protein (221- 229)
CancerH-2Db231CMTWNQMNLWT1 235-243
CancerH-2Db559HCIRNKSVIPSA 65-73
CancerH-2Db695Abu-Abu-L-Abu-LTVFLMoloney murine sarcoma virus (MoMSV) GagL 85-93
CancerH-2Db1333KVPRNQDWLgp100 (pmel17) 25-33
CancerH-2Db1780HCIRNKSVILhPSA
CancerH-2Db2198VILTNPISMVEGFR2 400-408
CancerH-2Db2199FSNSTNDILIVEGFR2/KDR fragment 1 614-624
CancerH-2Db2675STHVNHLHCEndophilin-B2 244-252
CancerH-2Db2695ASMTNMELMMC-38 Adpgk neoantigen
CancerH-2Db2755AQLANDVVLMC-38
CancerH-2Db3349ASFRNLTHLTPBG 258-266
CancerH-2Db202CRMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerH-2Kb351HNTQYCNLMAGEA5 5-12
CancerH-2Kb2311TVSEFLKLMurine Survivin 97-104
CancerH-2Kb185SVYDFFVWLTyrosinase related protein-2 180-188
CancerH-2Kb2585VGRNFTNLmTERT
CancerH-2Kb2754SIIVFNLLMC-38
CancerH-2Kb3373SDYYFSWLmuFAP 289-296
CancerH-2Kb3376SKYVFENVMybpc2 295-302
CancerH-2Kd343TYVPANASLNeu/Her-2/Erbb2 proto-oncoprotein 66-74
CancerH-2Kd485AYIDFEMKISART3 315-323
CancerH-2Kd814EYILSLEELGPC3 298-306
CancerH-2Kd3381SYMLQALCITNPO3
CancerH-2Ld150LPYLGWLVFTumour Antigen P815 35-43
ChlamydiaA*02:01334RLNMFTPYIChlamydia trachomatis MOMP 258-266
ChlamydiaA*02:01335NMFTPYIGVMOMP precursor 283-291
ChlamydiaB*27:053094ARKLLLDNLPqqC-like protein 70-78
ChlamydiaB*27:053945NRAKQVIKLProbable ATP-dependent Clp protease ATP-binding subunit 7-15
ChlamydiaH-2Db3943ASFVNPIYLCysteine-rich membrane protein 63-71
ChlamydiaH-2Db3947SAVSNLFYVPOMP 612-620
CMVA*01:01266YSEHPTFTSQYHCMV pp65 363-373
CMVA*01:01739VTEHDTLLYHCMV pp50 245-253
CMVA*02:018NLVPMVATVHCMV pp65 495-504
CMVA*02:01144VLEETSVMLHCMV IE1 316-324 (UL123)
CMVA*02:011598VLAELVKQIHCMV IE1 81-89
CMVA*02:012205MLNIPSINVpp65 120-128
CMVA*03:011599KLGGALQAKHCMV IE1 184-192
CMVA*24:02380VYALPLKMLHCMV pp65 113-121
CMVA*24:02414QYDPVAALFHCMV pp65 341-349
CMVA*24:023390AYAQKIFKICMV IE-1 248-256
CMVB*07:0245TPRVTGGGAMHCMV pp65 417-426
CMVB*07:02308RPHERNGFTVLHCMV pp65 265-275
CMVB*08:01127ELRRKMMYMIE1 199-207
CMVB*08:013391ELKRKMIYMCMV IE-1 199-207 (R/L Position 3, M/I Position 7)
CMVB*35:01114IPSINVHHYHCMV pp65 123-131
CMVC*06:023264TRATKMQVIpp65 211-219
CMVC*06:023744QIKVRVDMIE1 88-95
CMVC*07:023269CRVLCCYVLIE1 309-317
CMVH-2Db2313HGIRNASFIMCMV m45 985-993
CMVH-2Dd278AGPPRYSRIMCMV m164 257-265
CMVH-2Dd2167LGPISGHVLpp65 15-23
CMVH-2Kb1915TVYGFCLLMCMV M139 419-426
CMVH-2Kd3412CYYASRTKLMCMV m145 451-459
CMVH-2Ld21YPHFMPTNLMCMV IE1 168-176
COVID-19 / SARS-CoV-2A*01:014355FTSDYYQLYSARS-CoV-2 ORF3a 207-215 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014381TTDPSFLGRYSARS-CoV-2 Replicase polyprotein 1ab 1637-1646 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014382PTDNYITTYSARS-CoV-2 Replicase polyprotein 1ab 1621-1629 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014501CTDDNALAYYSARS-Cov-2 ORF1ab 4163-4172
COVID-19 / SARS-CoV-2A*01:014690HTTDPSFLGRYSARS-CoV-2 ORF1ab 1641-1651
COVID-19 / SARS-CoV-2A*01:014726IVDTVSALVYSARS-CoV-2 ORF1ab 5781-5789
COVID-19 / SARS-CoV-2A*02:014320LLLDRLNQLSARS-CoV Nucleocapsid protein 223-231 (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2A*02:014321FIAGLIAIVSARS-CoV-2 Spike glycoprotein 1220-1228 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014322ALNTLVKQLSARS-CoV Spike glycoprotein precursor 940-948 (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2A*02:014323LITGRLQSLSARS-CoV-2 Spike glycoprotein 996-1004 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014324NLNESLIDLSARS-CoV
Spike glycoprotein precursor 1174-1182 (conserved in SARS-Cov-2)
COVID-19 / SARS-CoV-2A*02:014326VLNDILSRLSARS-CoV Spike glycoprotein precursor 958-966 (conserved in SARS-Cov-2)
COVID-19 / SARS-CoV-2A*02:014339YLQPRTFLLSARS-Cov-2 Spike glycoprotein 269-277 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014342LLYDANYFLSARS-CoV-2 ORF3a 139-147 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014358RLQSLQTYVSARS-CoV-2 Spike glycoprotein 1000-1008 (confirmed subdominant epitope)
COVID-19 / SARS-CoV-2A*02:014418KLWAQCVQLSARS-CoV-2 ORF1ab 3886-3894 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014725TLVPQEHYVSARS-CoV-2 ORF1ab 5563-5571
COVID-19 / SARS-CoV-2A*02:014340KIADYNYKLSARS-CoV-2 Spike glycoprotein 417-425
COVID-19 / SARS-CoV-2A*03:014443KCYGVSPTKSARS-CoV-2 Spike glycoprotein 378-386
COVID-19 / SARS-CoV-2A*03:014724KLFAAETLKSARS-CoV-2 ORF1ab 5455-5463
COVID-19 / SARS-CoV-2A*03:014356AKTFPPTEPKSARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope)
COVID-19 / SARS-CoV-2A*03:014691AVTNNTFTLKSARS-CoV-2 ORF1ab 808-816
COVID-19 / SARS-CoV-2A*03:014679ASVYAWNRKRSARS-CoV-2 Spike glycoprotein 349-357
COVID-19 / SARS-CoV-2A*11:014356BKTFPPTEPKSARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope)
COVID-19 / SARS-CoV-2A*11:014691BVTNNTFTLKSARS-CoV-2 ORF1ab 808-816
COVID-19 / SARS-CoV-2A*11:014679BSVYAWNRKRSARS-CoV-2 Spike glycoprotein 349-357
COVID-19 / SARS-CoV-2A*24:024668QYIKWPWYISARS-CoV-2 Spike glycoprotein 1205-1213
COVID-19 / SARS-CoV-2A*24:024670VYIGDPAQLSARS-CoV-2 ORF1ab 5724-5732
COVID-19 / SARS-CoV-2A*24:024692NYNYLYRLFSARS-CoV-2 Spike glycoprotein 448-456
COVID-19 / SARS-CoV-2B*07:024351SPRWYFYYLSARS-CoV-2 Nucleocapsid protein 105-113 (confirmed epitope)
COVID-19 / SARS-CoV-2B*07:024694RARSVSPKLSARS-CoV-2 ORF7a 78-86
COVID-19 / SARS-CoV-2B*27:054354QRNAPRITFSARS-CoV-2 Nucleocapsid protein 9-17
COVID-19 / SARS-CoV-2B*40:014328MEVTPSGTWLSARS-CoV-2 Nucleocapsid protein 322-330 (confirmed epitope)
COVID-19 / SARS-CoV-2H-2Kb4549SIIAYTMSLSARS-CoV-2 Spike glycoprotein 691-699
COVID-19 / SARS-CoV-2H-2Kb4544VVLSFELLSARS-CoV-2 Spike glycoprotein 505-523
DengueA*02:012929TLYAVATTIDengue NS4b 40-48
DengueA*02:013910KLAEAIFKLDengue NS5 563-571
DengueA*02:013914ILIRTGLLVIDengue NS2b 97-106
DengueA*02:013918AIKRGLRTLDengue NS3 112-120
DengueA*02:013923LLLGLMILLDengue NS4a 56-64
DengueA*02:013928VLLLVTHYADengue NS4b 111-119
DengueA*03:013913ELERAADVKDengue NS2b 52-60
DengueA*03:013910ARVSTVQQLTKDengue C 22-31
DengueA*03:013916ARIEPSWADVKDengue NS3 64-74
DengueA*03:013921ARVIDPRRCMKDengue NS3 422-431
DengueA*03:013929AKITAEWLWKDengue NS5 375-383
DengueA*11:011843GTSGSPIINRDengue NS3 serotype 3&4 133-142
DengueA*11:012372GTSGSPIIDKDengue NS3 133-142
DengueA*11:012373GTSGSPIVNRNS3 serotype 1 133-142
DengueA*11:013459ATYGWNLVKDENV 1 NS5 2610-2618
DengueA*11:013460STYGWNIVKDENV 3 NS5 2607-2615
DengueA*11:013461STYGWNLVRDENV 2 NS5 2608-2616
DengueA*11:013906GTSGSPIVDRDengue NS3 serotype 2 133-142
DengueA*11:013907GTSGSPIADKDengue NS3 133-142
DengueA*11:014624GTSGSPIVDKDENV 2 NS3 1608-1617
DengueA*11:014625GTSGSPIINKDENV 4 NS3 1607-1617
DengueA*11:014626TIPPTAGILKDENV 2 Core 58-67
DengueA*11:014627TTLSRTSKKDENV 2 NS2a 1336-1344
DengueA*11:014628KTFDSEYVKDENV 2 Polyprotein 1863-1871
DengueA*11:014629KTFDSEYIKDENV 2 NS3 1863-1871
DengueA*11:014630KTFDTEYQKDENV 1 NS3 1864-1872
DengueA*11:014631ATVLMGLGKDENV 2 Polyprotein 2315-2323
DengueA*11:013910BRVSTVQQLTKDengue C 22-31
DengueA*11:013916BRIEPSWADVKDengue NS3 64-74
DengueA*11:013921BRVIDPRRCMKDengue NS3 422-431
DengueA*11:013929BKITAEWLWKDengue NS5 375-383
DengueA*24:023910QYSDRRWCFDengue NS3 557-565 (Singapore/S275/1990)
DengueA*24:024081TYGWNIVKLDENV 3 NS5 2608-2616
DengueA*24:024082TYGWNLVRLDENV 2 NS5 2609-2617
DengueA*24:024083TYGWNLVKLDENV 1, 4 NS5 2611-2619
DengueA*24:024632RYLEFEALGFDENV 3 NS5 2971-2980
DengueA*24:024633TYFQRVLIFDENV 2 M 261-269
DengueB*07:023909APTRVVAAEMDengue NS3 serotype 2 222-231
DengueB*08:013915RIKQKGILDengue NS3 25-32
DengueB*08:013925LEKTKKDLDengue NS4a 6-13
DengueB*15:013912CLIPTAMAFDengue C 107-115
DengueB*35:013908TPEGIIPTLDengue NS3 500-508
DengueB*40:013924GEARKTFVELDengue NS3 528-537
EBVA*02:011GLCTLVAMLEBV BMLF-1 259-267
EBVA*02:0142CLGGLLTMVEBV LMP-2 426-434
EBVA*02:01409YLLEMLWRLEBV LMP-1 125-133
EBVA*02:01410YLQQNWWTLEBV LMP1 159-167
EBVA*02:01462YVLDHLIVVEBV BRLF1 109-117
EBVA*02:01666FLYALALLLEBV LMP-2 356-364
EBVA*02:01872TLDYKPLSVEBV BMRF1 208-216
EBVA*02:011616LLDFVRFMGVEBV EBNA-3C 284-293
EBVA*02:012292FLDKGTYTLEBV BALF-4 276-284
EBVA*02:013462FMVFLQTHIEBV EBNA-1 (562-570)
EBVA*03:01727RLRAEAQVKEBV EBNA 3A 603-611
EBVA*03:011838RVRAYTYSKEBV BRLF1
EBVA*11:01199IVTDFSVIKEBV EBNA-4 416-424
EBVA*11:01508SSCSSCPLSKEBV LMP-2 340-349
EBVA*11:014183SSCSSCPLTKEBV LMP-2_EBVG
339-348
EBVA*11:01639ATIGTAMYKEBV BRLF1 134-142
EBVA*11:01726AVFDRKSDAKEBNA3B 399-408
EBVA*24:02420TYGPVFMCLEBV LMP-2 419-427
EBVA*24:02648PYLFWLAAIEBV LMP2 131-139
EBVA*24:02683TYGPVFMSLEBV LMP2 419-427
EBVB*07:0244RPPIFIRRLEBV EBNA-3A 247-255
EBVB*07:02647RPQGGSRPEFVKLEBV BMRF1 116-128
EBVB*07:022305QPRAPIRPIEBV EBNA-3C 881-889
EBVB*08:0173FLRGRAYGLEBV EBNA-3A 193-201
EBVB*08:01190RAKFKQLLEBV BZLF-1 190-197
EBVB*08:01489QAKWRLQTLEBV EBNA3A 158-166
EBVB*35:01107YPLHEQHGMEBV EBNA-3A 458-466
EBVB*35:01399EPLPQGQLTAYEBV BZLF-1 54-64
EBVB*35:013033HPVAEADYFEYEBV EBNA-1 407-417(4A)
EBVB*40:01692IEDPPFNSLEBV LMP2 200-208
HAVA*02:012257LLYNCCYHVHepatitis A Virus polyprotein 2027-2034
HAVB*07:022164HPRLAQRILHepatitis A Virus polyprotein 1877-1885
HBVA*01:013939LLDTASALYCore 30-38
HBVA*02:0123FLPSDFFPSVHBV core antigen 18-27
HBVA*02:0127FLLTRILTIHBV envelope 183-191
HBVA*02:0128GLSPTVWLSVHBV surface antigen 185-194
HBVA*02:0131WLSLLVPFVHBV surface antigen 172-181
HBVA*02:0132FLLSLGIHLHBV polymerase 573-581
HBVA*02:01283FLPSDFFPSIHBV core 18-27 (subtype ADR4)
HBVA*02:01500VLHKRTLGLX 92-100
HBVA*02:01778GLSRYVARLHBV Pol 455-463
HBVA*02:011194YMDDVVLGAPolymerase 548-556
HBVA*02:012829KLHLYSHPIPol 502-510
HBVA*02:013934ELMTLATWVcore protein 64-72
HBVA*11:01377YVNVNMGLKHBV core antigen 88-96
HBVA*11:012659YVNTNMGLKCore 88-96
HBVA*11:013941STLPETTVVRRCore 141-151
HBVA*24:02378EYLVSFGVWHBV core 117-125
HBVA*24:02413KYTSFPWLLHBV polymerase 756-764
HBVA*24:023935FFPSIRDLLcore protein 23-31
HBVB*07:02701LPSDFFPSVCore 19-27
HBVB*08:013937GLKILQLLexternal core Ag
HBVH-2Kb422ILSPFLPLLHBV surface antigen 208-216
HBVH-2Kb477VWLSVIWMHBV Surface antigen 190-197
HBVH-2Kb1431MGLKFRQLHBV core 93-100
HBVH-2Kd529WYWGPSLYSIlarge envelope 362-371
HBVH-2Kd3916SYVNTNMGLCore 87-95
HBVH-2Ld129IPQSLDSWWTSLHBV surface antigen 28-39
HCVA*01:01740ATDALMTGYHCV NS3 1435-1443
HCVA*01:011066ATDALMTGFHCV NS3 1436-1444
HCVA*02:012DLMGYIPAVHCV core 132-140
HCVA*02:013CINGVCWTVHCV NS3 1073-1081
HCVA*02:014YLLPRRGPRLHCV core 35-44
HCVA*02:0136VLSDFKTWLHCV NS5a 1987-1995
HCVA*02:0137ALYDVVTKLHCV NS5b 2594-2602
HCVA*02:0140KLVALGINAVHCV NS3 1406-1415
HCVA*02:01243KLSGLGLNAVHCV NS3 1406-1415
HCVA*02:01172LLFNILGGWVHCV NS4b 1807-1816
HCVA*02:01242KLSGLGINAVHCV NS3 1406-1415
HCVA*02:01491DLMGYIPLVHCV core 132-140
HCVA*02:01858CVNGVCWTVHCV NS3 1073-1081
HCVA*02:011094GLQDCTMLVHCV NS5B 2727-2735
HCVA*03:0135RVCEKMALYHCV NS5B 2588-2596
HCVA*24:02415AYSQQTRGLHCV NS3 1031-1039
HCVB*07:02742GPRLGVRATHCV core 41-49
HCVB*07:02845DPRRRSRNLHCV core 111-119
HCVB*08:01721HSKKKCDELHCV NS3 1395-1403
HCVB*27:05871ARMILMTHFNS5B 2841-2849
HCVB*35:01565HPNIEEVALHCV NS3 1359-1367
HCVB*35:01942CPNSSIVYHCV E1 207-214
HCVB*40:01939REISVPAEILHCV NS5a 2266-2275
HCVH-2Db791GAVQNEVTLHCV NS3 1629-1637
HIV/SIVA*02:0110SLYNTVATLHIV-1 gag p17 76-84
HIV/SIVA*02:0184ILKEPVHGVHIV-1 RT 476-484
HIV/SIVA*02:01174TLNAWVKVVHIV-1 gag p24 19-27
HIV/SIVA*02:01246KLTPLCVTLHIV-1 env gp120 90-98
HIV/SIVA*02:01430GLADQLIHLHIV-1 Vif 101-109
HIV/SIVA*02:01799LTFGWCFKLHIV-1 Nef 137-145
HIV/SIVA*02:011147FLGKIWPSGag 433-440
HIV/SIVA*02:011240ALVEMGHHAHIV Vpu 66-74
HIV/SIVA*02:011241RTLNAWVKVHIV Gag 150-158
HIV/SIVA*02:011244NVWATHACVHIV Env gp 67-7
HIV/SIVA*02:011537SLLNATAIAVHIV env 816-825
HIV/SIVA*02:013401SLFNTVATLHIV gag 77-85
HIV/SIVA*02:013402SLVKHHMYIHIV Vif 23-31
HIV/SIVA*02:013403VIYHYVDDLHIV Pol
HIV/SIVA*03:01109QVPLRPMTYKHIV-1 nef 73-82
HIV/SIVA*03:01194RLRPGGKKKHIV-1 gag p17 19-27
HIV/SIVA*03:011496AIFQSSMTKHIV pol 325-333
HIV/SIVA*11:011486AVDLSHFLKHIV nef 84-92
HIV/SIVA*11:011686ACQGVGGPGHKHIV gag p24
HIV/SIVA*24:02411RYPLTFGWCYHIV-1 Nef 134-143
HIV/SIVA*24:02419RYLKDQQLLHIV-1 gag gp41 67-75
HIV/SIVA*24:021805RYLRDQQLLHIV env
HIV/SIVA*24:023099RYPLTFGWCFHIV NEF 143-152
HIV/SIVA*24:023238RYPLTFGWHIV nef
HIV/SIVA*29:023392LYNTVATLYHIV gag 79-86
HIV/SIVA*29:023395SFDPIPIHYHIV env 216-224
HIV/SIVA*29:023396SFNCRGEFFYHIV env 382-391
HIV/SIVB*07:02196IPRRIRQGLHIV-1 env gp120 848-856
HIV/SIVB*07:02257TPGPGVRYPLHIV-1 nef 128-137
HIV/SIVB*07:02877GPGHKARVLHIV gag p24 223-231
HIV/SIVB*08:01193FLKEKGGLHIV-1 nef 90-97
HIV/SIVB*08:01195GEIYKRWIIHIV-1 gag p24 261-269
HIV/SIVB*08:01879EIYKRWIIHIV p24 gag 128-135
HIV/SIVB*08:011536YLKDQQLLEnv 586-593
HIV/SIVB*15:011072RLRPGGKKKYHIV-1 p17 20-29
HIV/SIVB*27:05294KRWIILGLNKHIV-1 gag p24 265-274
HIV/SIVB*27:05874KRWIIMGLNKHIV-1 Gag p24 263-272
HIV/SIVB*27:052306GRAFVTIGKHIV-1 gp100 103-111
HIV/SIVB*35:01255NPDIVIYQYHIV-1 HIV-1 RT 328-336
HIV/SIVB*35:011211VPLDEDFRKYHIV-1 HIV-1 RT 273-282
HIV/SIVB*40:01840KEKGGLEGLHIV-1 Nef 92-100
HIV/SIVH-2Db719AAVKNWMTQTLSIV gag
HIV/SIVH-2Dd177RGPGRAFVTIHIV-1 IIIB gp120 318-327
HIV/SIVH-2Dd1684IGPGRAFYAHIV-1 US4 gp120 318-326
HIV/SIVH-2Kd176AMQMLKETIHIV-1 gag p24 199-207
HIV/SIVH-2Kd403AMQMLKDTIHIV gag p24 197-205
HIV/SIVMamu-A*011110CTPYDINQMSIV Gag 181-189
HIV/SIVMamu-A*021111YTSGPGIRYSIV Nef 159-167
HIV/SIVMamu-A*021112GSENLKSLYSIV Gag 71-79
HPVA*02:0195YMLDLQPETTHPV 16 E7 11-20
HPVA*02:01658KLPQLCTELHPV 16 E6 18-26
HPVA*02:012103YMLDLQPETHPV E7 11-19
HPVA*02:012312MLDLQPETTHPV 16 E7 12-20
HPVA*03:012064KLCLRFLSKHPV 33 E6 64-72
HPVA*11:012067NTLEQTVKKHPV 33E6 86-94
HPVA*24:023240VYDFAFRDLHPV16 E6
HPVB*07:022065KPTLKEYVLHPV 33 E7 5-13
HPVH-2Db502HRAHYNIVTFHPV 16 E7 49-57
HPVH-2Db3404AGVDNRECIHPV L1 165-173
HPVH-2Kb2560EVYDFAFRDLHPV E6 48-57
HSVA*02:011152VLMIKALELNon muscle Myosin-9 741-749
HSVA*02:011153QLFNHTMFINon-muscle Myosin 478-486
HSVA*02:013406QMARLAWEA1116-1124
HSVH-2Db3405AAGPHNDMEIHSV p56 487-495
HSVH-2Dd3405BAGPHNDMEIHSV p56 487-495
HSVH-2Kb188SSIEFARLHSV-1 gp B 498-505
HSVH-2Kd3407TYWPVVSDI207-215
HTLVA*02:01200LLFGYPVYVHuman T-cell lymphotropic virus-1 (HTLV-1) tax 11-19
HTLVA*02:012309AVLDGLLSLHTLV bZIP factor 42-50
HTLVA*02:013408GLLSLEEELbZIP factor 26-34
HTLVA*24:021043SFHSLHLLFHTLV Tax 301-309
HTLVB*07:023400LPVSCPEDLbZIP factor 10-18
InfluenzaA*01:0176CTELKLSDYInfluenza A (PR8) NP 44-52
InfluenzaA*01:01540VSDGGPNLYInfluenza A PB1 591-599
InfluenzaA*02:017GILGFVFTLInfluenza A MP 58-66
InfluenzaA*02:012295ILGFVFTLTVInfluenza A MP 59-68
InfluenzaA*02:013409KLGEFYNQMMFlu BNP 85-94 (Influenza B)
InfluenzaA*03:0177ILRGSVAHKInfluenza A (PR8) NP 265-274
InfluenzaA*11:011513SIIPSGPLKInfluenza A MP 13-21
InfluenzaA*11:011720RMVLASTTAKInfluenza A MP1 178-187
InfluenzaA*11:011722KSMREEYRKInfluenza A MP2 70-78
InfluenzaB*07:021743QPEWFRNVLInfluenza A PB1 329-337
InfluenzaB*07:021744SPIVPSFDMInfluenza A NP 473-481
InfluenzaB*27:05463SRYWAIRTRInfluenza A NP 383-391
InfluenzaH-2Db9ASNENMDAMInfluenza A (NT60) NP 366-374
InfluenzaH-2Db119ASNENMETMInfluenza A (PR8) NP 366-374
InfluenzaH-2Db3410SCLENFRAYVInfluenza A polymerease PA 224-233
InfluenzaH-2Db120SSLENFRAYVInfluenza A (PR8) Polymerase acidic protein 224-233
InfluenzaH-2Kd98TYQRTRALVInfluenza A (PR8) NP 147-155
InfluenzaH-2Kd240IYSTVASSLInfluenza A HA 533-541
JC VirusA*02:01610SITEVECFLVP1 36-44
JC VirusA*02:01611ILMWEAVTLVP1 100-108
LCMVA*02:012308ALPHIIDEVLCMV envelope gp 10-18
LCMVA*02:012310YLVSIFLHLLCMV envelope gp 447-455
LCMVA*02:013411SLNQTVHSLNP 69-77
LCMVH-2Kb2076ISHNFCNLLCMV GP 118-125
LCMVH-2Db69KAVYNFATCLCMV GP1 33-41
LCMVH-2Db70FQPQNGQFILCMV NP 396-404
LCMVH-2Db142KAVYNFATMgp33 (C9M)
LCMVH-2Db186SGVENPGGYCLLCMV GP 276-286
ListeriaH-2Kd178GYKDGNEYIListeria monocytogenes Listeriolysin 91-99
MalariaA*02:01314YLNKIQNSLPlasmodium falciparum CSP 334-342
MalariaH-2Db2697SQLLNAKYLPlasmodium berghei ANKA acid phosphatase 40-48
MalariaH-2Kd376SYIPSAEKIPlasmodium berghei CSP 252-260
MalariaH-2Kd2290SYVPSAEQIPlasmodium CSP
MalariaH-2Kd771YYIPHQSSLPlasmodium falciparum Liver stage antigen 1671-1679
Minor Histocompatibility AntigenA*01:01652IVDCLTEMYDRRFY 1521-1529
Minor Histocompatibility AntigenH-2Kk269TENSGKDISMCY 1332-1339
Minor Histocompatibility AntigenA*02:01175FIDSYICQVmiHAg H-Y (human SMCY) 311-319
Minor Histocompatibility AntigenA*02:01395YIGEVLVSVHA-2
Minor Histocompatibility AntigenA*02:01473VLHDDLLEAMinor Histocompatibility Antigen HA-1 137-145
Minor Histocompatibility AntigenA*02:01581RTLDKVLEVmiHAg HA-8
Minor Histocompatibility AntigenB*07:021113SPSVDKARAELMiHAg SMCY 1041-1051
Minor Histocompatibility AntigenH-2Db327WMHHNMDLImiHAg UTY 246-254
Minor Histocompatibility AntigenH-2Db328KCSRNRQYLmiHAg SMCY 738-746
Model AntigensH-2Kb93SIINFEKLOvalbumin 257-264
Model AntigensH-2Kb562LTFNYRNLHistocompatibility antigen 60 39-46
Model AntigensH-2Kb908KVVRFDKLOvalbumin (subdominant) 55-62
Model AntigensH-2Kb1803SIYRYYGLSynthetic variant of VSV Nucleoprotein 498-505
Model AntigensH-2Kd198HYLSTQSALEnhanced Green Fluorescent Protein (eGFP) 200-208
Model AntigensH-2Ld74TPHPARIGLE. coli beta-galactosidase 876-884
MuLVH-2Kb828KSPWFTTLMuLV env 622-629 (MC38)
MuLVH-2Ld398SPSYVYHQFMuLV env gp70 423-431
NegativeA*02:01N01NEGATIVENegative Control
NorovirusA*02:013214TMFPHIIVDVNorovirus VP1 139-148
OtherA*02:01133LLDVPTAAVInterferon gamma inducible protein (GILT) 30 27-35
OtherA*02:01353RILGAVAKVVinculin 822-830
OtherA*02:01366LMWYELSKIKSHVF-8 gB.492-500
OtherA*02:013041ILEDIVLTLStreptococcus pyogenes Cas9 615-623
OtherA*02:01370TIHDIILECVAlpha papillomavirus 9 E6 Protein (22-31)
OtherE*01:01712VMAPRTLILHLA-C leader sequence peptide
OtherE*01:012355VMAPRTLVLHLA-A leader sequence peptide
OtherH-2Dk339RRLGRTLLLPolyoma virus middle T protein 389-397
OtherH-2Kb2331TSINFVKIMHV 524-431
OtherH-2Kd62RYLKNGKETLHLA-Cw3 170-179
OtherH-2Kd458KYNKANVFLNRP-V7 superagonist peptide 8.3 Tg NOD mouse
OtherH-2Kd3414IYNVGQVSILeptospira
OtherH-2Ld
3051LPNWGKYVLRabies Glycoprotein (453-461)
RSVA*02:01801KMLKEMGEVRSV NP 137-145
RSVH-2Kd149KYKNAVTELRSV A strain F protein 85-93
RSVH-2Kd154SYIGSINNIRespiratory Syncytial Virus (RSV) M2 82-90
Sendai VirusH-2Kb56FAPGNYPALSendai virus NP 324-332
SV40H-2Kb488VVYDFLKLSV40 T antigen 404-411
Toxoplasma gondiiH-2Kb2156SVLAFRRLtgd057 57-64
Trypanosoma CruziH-2Kb708ANYNFTLVTrypanosoma cruzi SP 536-543
Trypanosoma CruziH-2Kb964VNHRFTLVTrypanosoma cruzi ASP-2 553-560
Trypanosoma cruziH-2Kk3415TEWETGQIASP-2 320-327
TuberculosisA*02:01276KLIANNTRVMycobacterium bovis antigen 85-A 200-208
TuberculosisA*02:01324GLPVEYLQVMycobacterium bovis antigen 85-A 6-14
TuberculosisA*02:01619GILTVSVAV16 kDa
TuberculosisA*02:01620AMASTEGNVESAT-6
TuberculosisA*02:012221VLTDGNPPEV19 kDa
TuberculosisH-2Db547AIQGNVTSIMycobacterium tuberculosis ESAT-6 17-25
TuberculosisH-2Kb764IMYNYPAMMycobacterium tuberculosis TB10.4 4-11
TuberculosisH-2Kb769IMYNYPAMLMycobacterium tuberculosis TB10.4 4-12
TuberculosisH-2Kd1263VYAGAMSGLMtb85A 145-152
TuberculosisH-2Ld158MPVGGQSSFMycobacterium tuberculosis Ag85A 70-78
VacciniaA*02:01703KVDDTFYYVVaccinia virus Host range protein 2 74-82
VacciniaA*02:01978ILDDNLYKVVaccinia virus Copenhagen Protein G5 18-26
VacciniaH-2Kb733TSYKFESVVaccinia virus WR epitope B8R 20-27
Varicella Zoster VirusA*02:01995ALWALPHAAIE62 593-601
Vesicular Stomatitis VirusH-2Kb373RGYVYQGLVSV NP 52
Vesicular Stomatitis VirusH-2Ld622MPYLIDFGLVSV N 275-283
West NileA*02:011320RLDDDGNFQLWest Nile Virus NY-99 polyprotein precursor (1452-1461)
West NileA*02:011322ATWAENIQVWest Nile virus NY-99 polyprotein precursor 3390-3398
West NileA*02:011327YTMDGEYRLWest Nile virus NY-99 polyprotein precursor 2023-2031
West NileH-2Db663LGMSNRDFLWest Nile Virus polyprotein 294-302
West Nile VirusA*02:011321SVGGVFTSVWNV envelope gp 430-438
West Nile VirusA*02:011324SLFGQRIEVWNV nonstructural protein 4B 15-23
Yellow Fever VirusA*02:012097LLWNGPMAVNS4B 214-222
Yellow Fever virusC*06:023942TRRFLPQILNS3 205-213
Yellow Fever VirusH-2Kb1182ATLTYRMLYellow Fever Virus 17D polyprotein 268-275

(back to top)

© Copyright ProImmune Ltd. 2001-2024. All Rights Reserved